A Polyclonal Spread Emerged: Characteristics of Carbapenem-Resistant  Isolates from the Intensive Care Unit in a Chinese Tertiary Hospital

ZHENGZHENG WANG; FANGYOU YU; XIAOFEI SHEN; MEILAN LI

Journal & Issue Details

Polish Journal of Microbiology

Journal Details

Format: Journal
eISSN: 2544-4646
First Published: 04 Mar 1952
Publication timeframe: 4 times per year
Languages: English

Klebsiella pneumoniae is regarded as an opportunistic Gram-negative pathogen that can cause several infections such as pneumonia, urinary tract infections, and bloodstream infections (Magill et al. 2014). Due to the overuse of carbapenems for treating severe infections caused by extended-spectrum β-lactamases (ESBLs)-producing bacteria, carbapenem-resistant K. pneumoniae (CRKP) has rapidly increased globally in the past decade (Logan and Weinstein 2017). The expression of plasmid-mediated carbapenemases has been the primary mechanism of carbapenem resistance, and K. pneumoniae carbapenemase (KPC) is the most frequent type found in this species (Martin and Bachman 2018). Among these isolates, ST11 was the predominant clone responsible for disseminating the resistance gene bla_KPC-2 in China (Qi et al. 2011), whereas ST258 accounted for the large majority of KPC-producing K. pneumoniae in the world (Kitchel et al. 2009; Hammerum et al. 2010). Moreover, additional types of carbapenemases have also emerged in K. pneumoniae like NDM-1 and OXA-48 categorized as class B metallo-β-lactamase (MBL) and class D enzymes, respectively, which confer specific levels of resistance to carbapenems. Ever since NDM-1 was discovered in K. pneumoniae isolate collected from a Swedish patient who had been hospitalized in India in 2008 (Yong et al. 2009), twenty-four NDM variants have been identified. It poses a significant threat to public health and a severe challenge for clinical treatments (Wu et al. 2019).

ICU hospitalization itself has been considered as an independent risk factor for CRKP acquisition (Schwaber et al. 2008; Hussein et al. 2009; Debby et al. 2012). The estimated detection rate of CRKP in patients admitted to intensive care units increased by 75% in a 20-year surveillance study in China (Tian et al. 2019). The gastrointestinal carriage rate of CRKP among ICU patients could reach 39.0–74.5%. It can be recognized as a reservoir of CRKP for progression from colonization to infection and the potential route of transmission of carbapenem resistance genes (Bratu et al. 2005; Snitkin et al. 2012; Papadimitriou-Olivgeris et al. 2013). Additionally, ICU is often deemed the epicenter of nosocomial infections caused by multidrug-resistant organisms (MDRO) due to the burdens of the vulnerable populations of critically immunocompromised patients and multiple invasive procedures. Thus, the outcome of patients with CRKP infections is inferior, leading to higher mortality in the setting of ICU associated with limited therapeutic options (Vardakas et al. 2015).

Herein, we report an investigation of CRKP carriage and acquisition in the ICU to illustrate the clonal spread of CRKP isolates, their phenotypic and genotypic characteristics, and to track their evolutionary traits further.

Experimental

Materials and Methods

CRKP isolates and Antimicrobial Susceptibility Testing. All the carbapenem-resistant K. pneumoniae strains were isolated from clinical specimens of the ICU patients in our hospital (Hwa Mei Hospital, University of Chinese Academy of Sciences, Ningbo, China) between October 2016 and March 2019. The identification of these isolates and antimicrobial susceptibility testing were done using the VITEK 2 Compact automated system (BioMérieux, Marcy l’Etoile, France). The routine antibiotic panel comprised ertapenem, amoxicillin/clavulanic acid, amikacin, aztreonam, ciprofloxacin, ceftriaxone, cefazolin, nitrofurantoin, cefepime, cefoxitin, gentamicin, imipenem, levofloxacin, trimethoprim/sulfamethoxazole, tobramycin, piperacillin/tazobactam, ampicillin, and tigecycline. The susceptibilities to ertapenem, imipenem, and tigecycline were confirmed by the disk diffusion method or E-test. According to manufacturer’s instructions, Enterobacter hormaechei ATCC 700323 and Escherichia coli ATCC 25922 were used as controls for species identification and susceptibility testing, respectively. The isolates resistant to either ertapenem or imipenem were defined as CRKP isolates in this study. Antimicrobial susceptibility results were interpreted by the criteria of the Clinical and Laboratory Standards Institute (CLSI 2018). Patient clinical information was acquired from electronic medical records, and the Ethics Committee of our hospital approved the study.

Detection of resistance determinants. All the isolates studied were tested for the production of carbapenemases by the modified carbapenem inactivation method (mCIM) recommended by CLSI (CLSI 2018). The genes encoding carbapenemases were investigated by polymerase chain reaction (PCR) using a series of primers as previously reported (Queenan and Bush 2007; Nordmann et al. 2011). The amplification products were sent for DNA sequencing (Qingke Biotech, Hangzhou).

Isolates genotyping. CRKP isolates in the study were genotyped by multilocus sequence typing (MLST). Seven housekeeping genes including gapA, infB, mdh, pgi, phoE, rpoB, and tonB of K. pneumoniae were amplified and sequenced based on protocols as described (Diancourt et al. 2005). Sequence types (STs) were identified using the online database at the Pasteur Institute multilocus sequence typing website for K. pneumoniae (http://www.pasteur.fr/recherche/genopole/PF8/mlst/Kpneumoniae.html). The evolutionary relationships between isolates were analyzed by the platform-independent Java software PHYLOVIZ using the goeBURST algorithm at a single-locus variant (SLV) level.

Results

Demographic and clinical characteristics of CRKP carriers. A total of 30 CRKP strains were isolated from 26 patients in the intensive care unit (ICU), and the strains from different isolation sites of the same patient were included in this study. Among these CRKP isolates, 12 (40%) were isolated from sputum specimens, and the remaining isolates were obtained from other types of specimens including blood (three, 10%), wound (two, 6.7%), drainage fluid (four, 13.3%), urine or urinary catheter (seven, 23.3%), and bronchial perfusate (one, 3.3%). 69.2% (18) of the patients were male, and 76.9% (20) were over 60 years old.

All patients had undergone invasive procedures such as tracheal intubation and central venous catheterization. During the ICU admission, multiple antimicrobials were used for the treatment of various intercurrent infections. Among the 26 patients with CRKP acquisition, five died, six declined further therapy, and 15 were discharged from the hospital ward. The times from acquisition of CRKP to death for the five patients who died, listed in order, were four, 107, 29, 36, and 16 days, respectively. Other detailed records of patients and information on the bacteria were summarized in Table I.

Table I

The corresponding bacterial characteristics and medical records of patients with CRKP acquisition.

Bacterial strain	Age	Isolation site	ST	Carbapenemases	Underlying conditions	Invasive procedures	Antimicrobial treatment	The length of stay	Outcomes
1025	61	Wound	NA	NDM-5	Septic shock, MODS, necrotizing fasciitis	Nasogastric tube, central venous catheter, surgical procedure	IMP, AMC, FEP, MXF, ISE	23 days	Survived
1029	81	Wound	ST722	NA	Pulmonary infection, hypertension, diabetes mellitus,	PICC catheter, mechanical ventilation heart disease, encephalorrhagia	IMP, TZP, SCF	46 days	Stable, discharged
1050	73	Blood	ST11	NDM-5	Septic shock, biliary tract infection, COPD, MODS, pulmonary failure	Mechanical ventilation, urinary catheter, deep vein catheter	TZP, IMP, MEM, SCF, TGC	55 days	Discontinuing treatment
1051	89	Sputum	ST11	NDM-5	Pulmonary infection, septic shock, pulmonary failure, hypertension, chronic renal failure, MDS, diabetes mellitus, hypertensive heart disease	Mechanical ventilation, urinary catheter, gastric tube	SCF, TGC	20 dTays	Death
1052	73	Sputum	ST11	NDM-5	Septic shock, biliary tract infection, COPD, MODS, pulmonary failure	Mechanical ventilation, urinary catheter, deep vein catheter	TZP, IMP, MEM, SCF, TGC	34 days	Discontinuing treatment
1055	46	Drainage fluid	ST1446	NA	Pulmonary infection, pyothorax, septic shock, pulmonary failure, renal insufficiency, liver cirrhosis	Mechanical ventilation, urinary catheter, deep vein catheter, gastric tube	IMP, TZP, SCF	38 days	Discontinuing treatment
1062	79	Bronchial perfusate	ST290	NDM-5	Pulmonary infection, chronic bronchitis, pulmonary failure, hypertension, cerebral infarction, pleural effusion	Mechanical ventilation, urinary catheter, deep vein catheter, gastric tube	SCF, AMC, FEP	26 days	Survived
1063	79	Sputum	ST290	NDM-5	Pulmonary infection, chronic bronchitis, pulmonary failure, hypertension, cerebral infarction, pleural effusion	Mechanical ventilation, urinary catheter, deep vein catheter, gastric tube	SCF, AMC, FEP	26 days	Survived
1064	61	Urine	ST290	NDM-5	Spinal cord injury, high falling injury, electric injury, pulmonary infection, pulmonary failure, fracture	Mechanical ventilation, urinary catheter, deep vein catheter, gastric tube	TZP, MEM, SCF	83 days	Stable, discharged
1076	42	Sputum	ST290	NDM-5	Craniocerebral trauma, pulmonary contusion, hemorrhagic shock, deep venous thrombosis, renal failure	Mechanical ventilation, urinary catheter, deep vein catheter	TZP, AMC, FEP, ISE, MEM, SCF	136 days	Death
1102	79	Sputum	ST290	NDM-5	Pulmonary infection, pulmonary failure, chronic bronchitis, parkinson	Mechanical ventilation, urinary catheter, deep vein catheter, gastric tube, surgical procedure	SCF, IMP, TZP	123 days	Survived
1165	76	Drainage fluid	ST11	KPC	Gastric perforation, peritonitis, fistulo of colon, pulmonary infection, liver cirrhosis	Mechanical ventilation, urinary catheter, deep vein catheter	TZP, IMP, AMC, FEP, TGC, SCF	18 days	Discontinuing treatment
1233	38	Drainage fluid	ST290	NA	Retroperitoneal abscess, acute necrotizing pancreatitis, hepatic insufficiency, hyperlipemia	Mechanical ventilation, urinary catheter, deep vein catheter, central venous catheter, drainage tube	TZP, LEV, IMP	46 days	Discontinuing treatment
1247	72	Urinary catheter	ST11	KPC	NMS, pulmonary infection, pulmonary failure, diabetes mellitus, hypertension, renal or hepatic insufficiency, hyperlipemia	Mechanical ventilation, urinary catheter, deep vein catheter	TZP	27 days	Stable, discharged
1762	57	Sputum	ST11	KPC	Septic shock, pulmonary encephalopathy, COPD, pulmonary failure, hypertension, fungal infection	Mechanical ventilation, urinary catheter, deep vein catheter	SCF, IMP, AMK, FEP	45 days	Death
1773	88	Urinary catheter	ST11	NA	Pulmonary infection, pulmonary failure, cerebral infarction, hypertension, diabetes mellitus, alzheimer disease	Mechanical ventilation, urinary catheter, gastric tube	TZP, IMP	35 days	Stable, discharged
1779	39	Urinary catheter	ST111	NA	MODS, pulmonary failure, traumatic shock, multiple fracture, sepsis, pulmonary infection, fungal infection	Mechanical ventilation, urinary catheter, deep vein catheter	IMP, SCF, ISE, MXF	183 days	Survived
1785	72	Urinary catheter	ST11	KPC	SCAP, pulmonary failure, urinary tract infection, diabetes mellitus, septic shock, fungal infection, pleural effusion	Mechanical ventilation, urinary catheter, deep vein catheter	IMP, SCF, TGC, AZM, MXF	31 days	Discontinuing treatment
1793	70	Urinary catheter	NA	NA	Pulmonary infection, pulmonary failure, septic shock, fungal infection, cerebral infarction, hypertension, diabetes mellitus, gastrointestinal hemorrhage	Mechanical ventilation, urinary catheter, deep vein catheter, gastrointestinal tube	TZP, SCF, CIP, FEP	40 days	Survived
1932	75	Sputum	ST11	NA	Lung cancer, pulmonary infection, bronchiectasis, CHD, hypertension, diabetes mellitus	Mechanical ventilation, urinary catheter, deep vein catheter	TZP, SCF, IMP, TGC	87 days	Survived
1948	78	Sputum	ST896	KPC	Cerebral aneurysm, subarachnoid hemorrhage, intracranial infection, pulmonary infection, deep venous thrombosis, fungal infection	Mechanical ventilation, urinary catheter	TZP, MEM, LEV, ISE, IMP, PB	63 days	Stable, discharged
1975	85	Sputum	ST11	KPC	Pulmonary infection, pulmonary failure, cardiac failure, cerebral infaction, hypertension	Mechanical ventilation, urinary catheter, deep vein catheter, PICC catheter	IMP, TZP, TGC	66 days	Stable, discharged
1977	85	Sputum	ST11	KPC	COPD, pneumonia, pulmonary failure, pulmonary encephalopathy, cardiac failure, renal failure, pulmonary arterial hypertension	Mechanical ventilation, urinary catheter, deep vein catheter, PICC catheter	IMP, SCF, TGC, PB, CAZ/AVI	46 days	Death
1978	78	Sputum	ST11	KPC	Pulmonary infection, severe pneumonia, pulmonary failure, renal failure, hypertension, hepatic insufficiency, gastrointestinal hemorrhage, deep venous thrombosis	Mechanical ventilation, urinary catheter, deep vein catheter	SCF, MXF, MEM, IMP, TGC, AMK, PB, CAZ/AVI, MH	51 days	Discontinuing treatment
1982	70	Sputum	ST11	NDM-1, KPC	Tonsil carcinoma, hypertension, hyperlipemia, interstitial pneumonia, pulmonary failure, fungal infection	Mechanical ventilation, urinary catheter, deep vein catheter	IMP	47 days	Stable, discharged
1983	82	Urinary catheter	ST11	KPC	COPD, pulmonary failure, pulmonary encephalopathy, diabetes mellitus, hypertension, fracture, septic shock, gastrointestinal hemorrhage	Mechanical ventilation, urinary catheter, deep vein catheter, PICC catheter	TZP, IMP, SCF	37 days	Death
1984	66	Drainage fluid	NA	NDM-1	Peritonitis, septic shock, pulmonary failure, renal failure, hypertension, fungal infection, intestinal perforation	Mechanical ventilation, urinary catheter, deep vein catheter, PICC catheter, drainage tube	IMP, TGC, TZP, SCF	43 days	Stable, discharged
1987	89	Sputum	ST11	KPC	Severe pneumonia, pulmonary failure, CHD, hypertension, rectal cancer, myocardial infarction, fungal infection	Mechanical ventilation, urinary catheter, deep vein catheter	TZP, MEM, SCF, PB, TGC, CAZ/AVI	22 days	Survived
1990	85	Blood	ST11	KPC	COPD, pneumonia, pulmonary failure, pulmonary encephalopathy, cardiac failure, renal failure, pulmonary arterial hypertension	Mechanical ventilation, urinary catheter, deep vein catheter, PICC catheter	IMP, SCF, TGC, PB, CAZ/AVI	46 days	Death
1997	82	Blood	ST11	KPC	COPD, pulmonary failure, pulmonary encephalopathy, diabetes mellitus, hypertension, fracture, septic shock, gastrointestinal hemorrhage	Mechanical ventilation, urinary catheter, deep vein catheter, PICC catheter	TZP, IMP, SCF	37 days	Death

MODS – Multiple organ dysfunction syndrome, COPD – Chronic obstructive pulmonary disease, MDS – Myelodysplastic syndrome, NMS – Neuroletic malignant syndrome, CHD – Coronary heart disease, IMP – Imipenem, AMC – Amoxicillin/clavulanic acid, FEP – cefepime, MXF – moxifloxacin, ISE – isepamicin, TZP – piperacillin/tazobactam, SCF – cefperazone/sulbactam – MEM, meropenem, TGC – tigecycline, LEV – levofloxacin, AMK – amikacin, CIP – ciprofloxacin, PB – polymyxin B, CAZ/AVI – ceftazidime/avibactam, MH – minocycline, ST – sequence type, NA – not available

Antimicrobial susceptibility. The isolates in this study were resistant to nearly all clinically available antimicrobials; more than half of the isolates were only susceptible to one or two kinds of antimicrobials and were called extensive drug-resistant isolates. All isolates presented resistance to ertapenem, amoxicillin/clavulanic acid, cefoperazone/sulbactam cefazolin, cefoxitin, and ampicillin. The isolates were relatively susceptible to four antimicrobials: gentamicin, tigecycline, tobramycin, and amikacin, to which the resistance rates were 36.7, 30.0, 26.7, and 16.7%, respectively. The percentage of resistant isolates to each antibiotic was shown in Fig. 1.

Percentage of CRKP isolates resistant to a panel of antibiotics (30 isolates).
The X-axis displays the percentage of the isolates resistant to a given antibiotic (Y-axis). Distribution of the MICs of antibiotics were as follows: Ertapenem (MIC ≥ 2 μg/ml, n = 30), Amoxicillin/clavulanic acid (MIC ≥ 32/16 μg/ml, n = 30), Cefoperazone (MIC ≥ 64 μg/ml, n = 30), Cefazolin (MIC ≥ 8 μg/ml, n = 30), Cefoxitin (MIC ≥ 32 μg/ml, n = 30), Ampicillin (MIC ≥ 32 μg/ml, n = 30), Aztreonam (MIC ≥ 16 μg/ml, n = 29), Ceftriaxone (MIC ≥ 4 μg/ml, n = 29), Piperacillin-tazobactam (MIC ≥ 128/4 μg/ml, n = 29), Nitrofurantoin (MIC ≥ 128 μg/ml, n = 28), Ciprofloxacin (MIC ≥ 1 μg/ml, n = 25), Cefepime (MIC ≥ 16 μg/ml, n = 25), Imipenem (MIC ≥ 4 μg/ml, n = 25), Trimethoprim/sulfamethoxazole (MIC ≥ 4/76 μg/ml, n = 25), Levofloxacin (MIC ≥ 2 μg/ml, n = 22), Gentamicin (MIC ≥ 16 μg/ml, n = 11), Tigecycline (MIC ≥ 8 μg/ml, n = 9), Tobramycin (MIC ≥ 16 μg/ml, n = 8), Amikacin (MIC ≥ 64 μg/ml, n = 5).

Profiling of resistance determinants. The majority of 30 CRKP (n = 23, 76.7%) isolates were positive for the mCIM test. The results of PCR and DNA sequencing showed that nine isolates (30%) harbored the bla_NDM-5 gene, 12 isolates 40% harbored the bla_KPC-2 gene, and one isolate had the bla_NDM-1 gene. The coexistence of bla_NDM-1 and bla_KPC-2 in one isolate was also noticed. The carbapenemase-encoding genes were not detectable in seven isolates.

Bacterial clonal relatedness. Among 30 CRKP isolates, six sequence types (STs) were detected, namely ST722, ST1446, ST111, ST896, ST290, and ST11 as shown by MLST. ST290 and ST11 accounted for 20% (6/30) and 56.7% (17/30) of all isolates tested, whereas the other STs were sporadic. Three ST11 isolates carried bla_NDM-5, yet bla_KPC-2 was more likely to be identified among ST11 clones. By contrast, ST290 clones harbored only bla_NDM-5. Seven isolates that were negative for mCIM test belonged to diverse STs (ST722, ST1446, ST290, ST11, and ST111). Notably, two K. pneumoniae NDM-producers failed to be classified into any sequence types and there was the sole isolate that was negative for either mCIM or sequence typing. Figure 2 displays the annotated minimum spanning tree showing that ST1446, ST111, ST896, ST290, and ST11 clones belonged to different groups, except for ST722 listed in the sub-group of ST11 group.

The minimum spanning tree.
The relationships between different clones of six unique sequence types (ST290, ST11, ST722, ST1446, ST111, and ST896 emerging in the ICU. The graph was analyzed by PHYLOVIZ using the goeBURST algorithm at single-locus variant (SLV) level. ST11 node was colored in light green; other ST nodes were colored in dark green and manually dragged to the selected positions that were represented in red.

Discussion

In 2017, WHO published a global priority pathogens list of antibiotic-resistant bacteria, in which CRE was ranked among the Priority 1 pathogens (WHO 2017). Carbapenem-resistant K. pneumoniae, which is the most common carbapenem-resistant Enterobacteriaceae (CRE), has already generated a worrisome crisis of epidemiological, clinical, and infection control issues worldwide (Bradford et al. 2004; Maltezou et al. 2009), including the ICUs across China (Zhang et al. 2011; Yu et al. 2012; Yu et al. 2019).

In this study, we have described the polyclonal spread of CRKP isolates of six distinct sequence types (ST290, ST11, ST722, ST1446, ST111 and ST896) in the same ward (ICU). Among these isolates, two novel clones of ST722 and ST1446 were found, and they did not produce carbapenemases since the negative results of the mCIM test were obtained. It inferred that other mechanisms of resistance might be relevant such as hyperproduction of ESBL enzymes, AmpC β-lactamases, or alteration of outer membrane porins as well as regulation of efflux systems (Kaczmarek et al. 2006; Bush and Jacoby 2010; Filgona et al. 2015). The minimum spanning tree demonstrated that ST722 clone probably shared the same ancestor with ST11 clone in the evolutionary process. As for ST111, it has long been identified among carbapenem-resistant, and ESBL-producing K. pneumoniae isolates, e.g., obtained from Riyadh (uz Zaman et al. 2014), South India (Kumar et al. 2018), New York (Diago-Navarro et al. 2014), and New Zealand (Lester et al. 2011). Further, the ST11 K. pneumoniae, one type of clone responsible for the outbreak of multi-drug carbapenem-resistant K. pneumoniae in Riyadh, carried the OXA-48 gene, suggesting that the acquisition of carbapenem-resistance genes by K. pneumoniae of different STs may contribute to the emergence of diverse CRKP clones. By contrast, only one ST896 CRKP isolate that was identified from Heilongjiang Province in China harbored the bla_IMP-4, bla_SHV, and bla_TEM genes (Gong et al. 2018).

Therefore, this is also the first report on the observation of the bla_KPC-2-harboring ST896 CRKP clone in China.

ST290 CRKP isolates possessing the bla_NDM-5 gene were found disseminated in the ICU in this study. Interestingly, an outbreak of ST290 CRKP with blaNDM-5-positive took place in the same hospital’s wound ward, as we have reported previously (Wang et al. 2019), raising speculation that intra-hospital transmission might be one of the contributory factors to this situation. However, in line with previous reports (Qi et al. 2011; Hu et al. 2016), ST11 was still the predominant type of CRKP clone, accounting for more than half of the isolates. Of note, three CRKP isolates of ST11 clone harbored bla_NDM-5 instead of bla_KPC-2, showing that the genotypic shift occurred in ST11 clone, which was probably attributed to the free movement of plasmidborne genes responsible for carbapenem resistance among the clones within species as stated previously (Mathers et al. 2015). Moreover, the rise in the number of NDM-5-positive isolates of the ST11 clone generates the awareness of the propagation of the MBL genes in high-risk K. pneumoniae clones. ST11 clone could be a suitable vector for the rapid spread of carbapenem resistance mediated by genetic components such as plasmids, integrons, or transposons.

The ICU patients in this study suffered from at least three underlying diseases and underwent several surgical procedures causing damage of mucosal barriers, which could increase the risk of CRKP colonization and infection (Kofteridis et al. 2014). We found that 71.4% of patients aged over 80 years died, as did 85.7% of the patients who stayed in the ICU for more than one month, reflecting the challenges in managing the comorbidities of ICU patients. Additionally, the prolonged hospitalization of CRKP carriers may increase the frequency of patient-to-patient transmission of antimicrobial resistance. According to the medical records, local empirical antibiotic therapy could be administered in the ICU, e.g., cefepime combined with amoxicillin/clavulanic acid (Ji et al. 2015). Ceftazidime/avibactam, a relatively new salvage therapy against CRKP, was also used in some patients with different outcomes (those who survived, died, or for whom the treatment was discontinued). However, the resistance to these antibiotics has previously been revealed due to the MBL production, KPC-2 point mutation, and high KPC expression (Zhang et al. 2019). It indicates that the treatment with ceftazidime/avibactam against MBL-producing CRKP might fail if local variations in epidemiology and genomic evolution of antimicrobial resistance are not tracked. Hence, the focus on characteristics of CRKP in the ICU not only plays an essential role in guiding clinical practice for antibiotic use but also provides the recent information about the evolution of antimicrobial resistance and helps to assign urgently needed tactics for combating the spread of CRKP clones.

The limitations of this study are that we did not distinguish colonization from infection with CRKP, and the small number of isolates was insufficient to illustrate the prevalence of CRKP in the ICU comprehensively.

In conclusion, this is the first report on the polyclonal emergence of six unique STs (ST722, ST1446, ST111, ST896, ST290, and ST11) found in the same ward and on two ST722 and ST1446 clones as being the novel STs in China. Pathogens in the ICU evolve all the time due to intra- and inter-species interactions by the horizontal transfer of antibiotic resistance genes. The emergence of sporadic clones producing MBLs, e.g., producing NDM-5 CRKP isolates of ST290 and ST11 clones, is a warning signal of the genotypic switch in epidemic KPC-producing CRKP population. Therefore, valid interventions should be developed to avoid outbreaks caused by novel subclones.

Figures & Tables

The corresponding bacterial characteristics and medical records of patients with CRKP acquisition.

Bacterial strain	Age	Isolation site	ST	Carbapenemases	Underlying conditions	Invasive procedures	Antimicrobial treatment	The length of stay	Outcomes
1025	61	Wound	NA	NDM-5	Septic shock, MODS, necrotizing fasciitis	Nasogastric tube, central venous catheter, surgical procedure	IMP, AMC, FEP, MXF, ISE	23 days	Survived
1029	81	Wound	ST722	NA	Pulmonary infection, hypertension, diabetes mellitus,	PICC catheter, mechanical ventilation heart disease, encephalorrhagia	IMP, TZP, SCF	46 days	Stable, discharged
1050	73	Blood	ST11	NDM-5	Septic shock, biliary tract infection, COPD, MODS, pulmonary failure	Mechanical ventilation, urinary catheter, deep vein catheter	TZP, IMP, MEM, SCF, TGC	55 days	Discontinuing treatment
1051	89	Sputum	ST11	NDM-5	Pulmonary infection, septic shock, pulmonary failure, hypertension, chronic renal failure, MDS, diabetes mellitus, hypertensive heart disease	Mechanical ventilation, urinary catheter, gastric tube	SCF, TGC	20 dTays	Death
1052	73	Sputum	ST11	NDM-5	Septic shock, biliary tract infection, COPD, MODS, pulmonary failure	Mechanical ventilation, urinary catheter, deep vein catheter	TZP, IMP, MEM, SCF, TGC	34 days	Discontinuing treatment
1055	46	Drainage fluid	ST1446	NA	Pulmonary infection, pyothorax, septic shock, pulmonary failure, renal insufficiency, liver cirrhosis	Mechanical ventilation, urinary catheter, deep vein catheter, gastric tube	IMP, TZP, SCF	38 days	Discontinuing treatment
1062	79	Bronchial perfusate	ST290	NDM-5	Pulmonary infection, chronic bronchitis, pulmonary failure, hypertension, cerebral infarction, pleural effusion	Mechanical ventilation, urinary catheter, deep vein catheter, gastric tube	SCF, AMC, FEP	26 days	Survived
1063	79	Sputum	ST290	NDM-5	Pulmonary infection, chronic bronchitis, pulmonary failure, hypertension, cerebral infarction, pleural effusion	Mechanical ventilation, urinary catheter, deep vein catheter, gastric tube	SCF, AMC, FEP	26 days	Survived
1064	61	Urine	ST290	NDM-5	Spinal cord injury, high falling injury, electric injury, pulmonary infection, pulmonary failure, fracture	Mechanical ventilation, urinary catheter, deep vein catheter, gastric tube	TZP, MEM, SCF	83 days	Stable, discharged
1076	42	Sputum	ST290	NDM-5	Craniocerebral trauma, pulmonary contusion, hemorrhagic shock, deep venous thrombosis, renal failure	Mechanical ventilation, urinary catheter, deep vein catheter	TZP, AMC, FEP, ISE, MEM, SCF	136 days	Death
1102	79	Sputum	ST290	NDM-5	Pulmonary infection, pulmonary failure, chronic bronchitis, parkinson	Mechanical ventilation, urinary catheter, deep vein catheter, gastric tube, surgical procedure	SCF, IMP, TZP	123 days	Survived
1165	76	Drainage fluid	ST11	KPC	Gastric perforation, peritonitis, fistulo of colon, pulmonary infection, liver cirrhosis	Mechanical ventilation, urinary catheter, deep vein catheter	TZP, IMP, AMC, FEP, TGC, SCF	18 days	Discontinuing treatment
1233	38	Drainage fluid	ST290	NA	Retroperitoneal abscess, acute necrotizing pancreatitis, hepatic insufficiency, hyperlipemia	Mechanical ventilation, urinary catheter, deep vein catheter, central venous catheter, drainage tube	TZP, LEV, IMP	46 days	Discontinuing treatment
1247	72	Urinary catheter	ST11	KPC	NMS, pulmonary infection, pulmonary failure, diabetes mellitus, hypertension, renal or hepatic insufficiency, hyperlipemia	Mechanical ventilation, urinary catheter, deep vein catheter	TZP	27 days	Stable, discharged
1762	57	Sputum	ST11	KPC	Septic shock, pulmonary encephalopathy, COPD, pulmonary failure, hypertension, fungal infection	Mechanical ventilation, urinary catheter, deep vein catheter	SCF, IMP, AMK, FEP	45 days	Death
1773	88	Urinary catheter	ST11	NA	Pulmonary infection, pulmonary failure, cerebral infarction, hypertension, diabetes mellitus, alzheimer disease	Mechanical ventilation, urinary catheter, gastric tube	TZP, IMP	35 days	Stable, discharged
1779	39	Urinary catheter	ST111	NA	MODS, pulmonary failure, traumatic shock, multiple fracture, sepsis, pulmonary infection, fungal infection	Mechanical ventilation, urinary catheter, deep vein catheter	IMP, SCF, ISE, MXF	183 days	Survived
1785	72	Urinary catheter	ST11	KPC	SCAP, pulmonary failure, urinary tract infection, diabetes mellitus, septic shock, fungal infection, pleural effusion	Mechanical ventilation, urinary catheter, deep vein catheter	IMP, SCF, TGC, AZM, MXF	31 days	Discontinuing treatment
1793	70	Urinary catheter	NA	NA	Pulmonary infection, pulmonary failure, septic shock, fungal infection, cerebral infarction, hypertension, diabetes mellitus, gastrointestinal hemorrhage	Mechanical ventilation, urinary catheter, deep vein catheter, gastrointestinal tube	TZP, SCF, CIP, FEP	40 days	Survived
1932	75	Sputum	ST11	NA	Lung cancer, pulmonary infection, bronchiectasis, CHD, hypertension, diabetes mellitus	Mechanical ventilation, urinary catheter, deep vein catheter	TZP, SCF, IMP, TGC	87 days	Survived
1948	78	Sputum	ST896	KPC	Cerebral aneurysm, subarachnoid hemorrhage, intracranial infection, pulmonary infection, deep venous thrombosis, fungal infection	Mechanical ventilation, urinary catheter	TZP, MEM, LEV, ISE, IMP, PB	63 days	Stable, discharged
1975	85	Sputum	ST11	KPC	Pulmonary infection, pulmonary failure, cardiac failure, cerebral infaction, hypertension	Mechanical ventilation, urinary catheter, deep vein catheter, PICC catheter	IMP, TZP, TGC	66 days	Stable, discharged
1977	85	Sputum	ST11	KPC	COPD, pneumonia, pulmonary failure, pulmonary encephalopathy, cardiac failure, renal failure, pulmonary arterial hypertension	Mechanical ventilation, urinary catheter, deep vein catheter, PICC catheter	IMP, SCF, TGC, PB, CAZ/AVI	46 days	Death
1978	78	Sputum	ST11	KPC	Pulmonary infection, severe pneumonia, pulmonary failure, renal failure, hypertension, hepatic insufficiency, gastrointestinal hemorrhage, deep venous thrombosis	Mechanical ventilation, urinary catheter, deep vein catheter	SCF, MXF, MEM, IMP, TGC, AMK, PB, CAZ/AVI, MH	51 days	Discontinuing treatment
1982	70	Sputum	ST11	NDM-1, KPC	Tonsil carcinoma, hypertension, hyperlipemia, interstitial pneumonia, pulmonary failure, fungal infection	Mechanical ventilation, urinary catheter, deep vein catheter	IMP	47 days	Stable, discharged
1983	82	Urinary catheter	ST11	KPC	COPD, pulmonary failure, pulmonary encephalopathy, diabetes mellitus, hypertension, fracture, septic shock, gastrointestinal hemorrhage	Mechanical ventilation, urinary catheter, deep vein catheter, PICC catheter	TZP, IMP, SCF	37 days	Death
1984	66	Drainage fluid	NA	NDM-1	Peritonitis, septic shock, pulmonary failure, renal failure, hypertension, fungal infection, intestinal perforation	Mechanical ventilation, urinary catheter, deep vein catheter, PICC catheter, drainage tube	IMP, TGC, TZP, SCF	43 days	Stable, discharged
1987	89	Sputum	ST11	KPC	Severe pneumonia, pulmonary failure, CHD, hypertension, rectal cancer, myocardial infarction, fungal infection	Mechanical ventilation, urinary catheter, deep vein catheter	TZP, MEM, SCF, PB, TGC, CAZ/AVI	22 days	Survived
1990	85	Blood	ST11	KPC	COPD, pneumonia, pulmonary failure, pulmonary encephalopathy, cardiac failure, renal failure, pulmonary arterial hypertension	Mechanical ventilation, urinary catheter, deep vein catheter, PICC catheter	IMP, SCF, TGC, PB, CAZ/AVI	46 days	Death
1997	82	Blood	ST11	KPC	COPD, pulmonary failure, pulmonary encephalopathy, diabetes mellitus, hypertension, fracture, septic shock, gastrointestinal hemorrhage	Mechanical ventilation, urinary catheter, deep vein catheter, PICC catheter	TZP, IMP, SCF	37 days	Death

References

Bradford PA, Bratu S, Urban C, Visalli M, Mariano N, Landman D, Rahal JJ, Brooks S, Cebular S, Quale J. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City. Clin Infect Dis. 2004 Jul 01;39(1): 55–60. https://doi.org/10.1086/421495BradfordPABratuSUrbanCVisalliMMarianoNLandmanDRahalJJBrooksSCebularSQualeJ. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City. Clin Infect Dis.2004Jul01;39(1): 55–60. https://doi.org/10.1086/42149510.1086/42149515206053Search in Google Scholar

Bratu S, Landman D, Haag R, Recco R, Eramo A, Alam M, Quale J. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch Intern Med. 2005 Jun 27;165(12):1430–1435. https://doi.org/10.1001/archinte.165.12.1430BratuSLandmanDHaagRReccoREramoAAlamMQualeJ. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch Intern Med.2005Jun27;165(12):1430–1435. https://doi.org/10.1001/archinte.165.12.143010.1001/archinte.165.12.143015983294Search in Google Scholar

Bush K, Jacoby GA. Updated functional classification of beta-lactamases. Antimicrob Agents Chemother. 2010 Mar;54(3):969–976. https://doi.org/10.1128/AAC.01009-09BushKJacobyGA. Updated functional classification of beta-lactamases. Antimicrob Agents Chemother.2010Mar;54(3):969–976. https://doi.org/10.1128/AAC.01009-0910.1128/AAC.01009-09282599319995920Search in Google Scholar

CLSI. Performance standards for antimicrobial susceptibility testing, 28th Inforational Supplement (M100-S28). Wayne (USA): Clinical and Laboratory Standards Institute; 2018.CLSI. Performance standards for antimicrobial susceptibility testing, 28th Inforational Supplement (M100-S28). Wayne (USA): Clinical and Laboratory Standards Institute; 2018.Search in Google Scholar

Debby BD, Ganor O, Yasmin M, David L, Nathan K, Ilana T, Dalit S, Smollan G, Galia R. Epidemiology of carbapenem resistant Klebsiella pneumoniae colonization in an intensive care unit. Eur J Clin Microbiol Infect Dis. 2012 Aug;31(8):1811–1817. https://doi.org/10.1007/s10096-011-1506-5DebbyBDGanorOYasminMDavidLNathanKIlanaTDalitSSmollanGGaliaR. Epidemiology of carbapenem resistant Klebsiella pneumoniae colonization in an intensive care unit. Eur J Clin Microbiol Infect Dis.2012Aug;31(8):1811–1817. https://doi.org/10.1007/s10096-011-1506-510.1007/s10096-011-1506-522246509Search in Google Scholar

Diago-Navarro E, Chen L, Passet V, Burack S, Ulacia-Hernando A, Kodiyanplakkal RP, Levi MH, Brisse S, Kreiswirth BN, Fries BC. Carbapenem-resistant Klebsiella pneumoniae exhibit variability in capsular polysaccharide and capsule associated virulence traits. J Infect Dis. 2014 Sep 01;210(5):803–813. https://doi.org/10.1093/infdis/jiu157Diago-NavarroEChenLPassetVBurackSUlacia-HernandoAKodiyanplakkalRPLeviMHBrisseSKreiswirthBNFriesBC. Carbapenem-resistant Klebsiella pneumoniae exhibit variability in capsular polysaccharide and capsule associated virulence traits. J Infect Dis.2014Sep01;210(5):803–813. https://doi.org/10.1093/infdis/jiu15710.1093/infdis/jiu157443239524634498Search in Google Scholar

Diancourt L, Passet V, Verhoef J, Grimont PAD, Brisse S. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol. 2005 Aug 01;43(8):4178–4182. https://doi.org/10.1128/JCM.43.8.4178-4182.2005DiancourtLPassetVVerhoefJGrimontPADBrisseS. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol.2005Aug01;43(8):4178–4182. https://doi.org/10.1128/JCM.43.8.4178-4182.200510.1128/JCM.43.8.4178-4182.2005123394016081970Search in Google Scholar

Filgona J, Banerjee T, Anupurba S. Role of efflux pumps inhibitor in decreasing antibiotic resistance of Klebsiella pneumoniae in a tertiary hospital in North India. J Infect Dev Ctries. 2015 Aug 29;9(08):815–820. https://doi.org/10.3855/jidc.6216FilgonaJBanerjeeTAnupurbaS. Role of efflux pumps inhibitor in decreasing antibiotic resistance of Klebsiella pneumoniae in a tertiary hospital in North India. J Infect Dev Ctries.2015Aug29;9(08):815–820. https://doi.org/10.3855/jidc.621610.3855/jidc.621626322872Search in Google Scholar

Gong X, Zhang J, Su S, Fu Y, Bao M, Wang Y, Zhang X. Molecular characterization and epidemiology of carbapenem non-susceptible Enterobacteriaceae isolated from the Eastern region of Heilongjiang Province, China. BMC Infect Dis. 2018 Dec;18(1):417. https://doi.org/10.1186/s12879-018-3294-3GongXZhangJSuSFuYBaoMWangYZhangX. Molecular characterization and epidemiology of carbapenem non-susceptible Enterobacteriaceae isolated from the Eastern region of Heilongjiang Province, China. BMC Infect Dis.2018Dec;18(1):417. https://doi.org/10.1186/s12879-018-3294-310.1186/s12879-018-3294-3610693830134844Search in Google Scholar

Hammerum AM, Hansen F, Lester CH, Jensen KT, Hansen DS, Dessau RB. Detection of the first two Klebsiella pneumoniae isolates with sequence type 258 producing KPC-2 carbapenemase in Denmark. Int J Antimicrob Agents. 2010 Jun;35(6):610–612. https://doi.org/10.1016/j.ijantimicag.2010.01.024HammerumAMHansenFLesterCHJensenKTHansenDSDessauRB. Detection of the first two Klebsiella pneumoniae isolates with sequence type 258 producing KPC-2 carbapenemase in Denmark. Int J Antimicrob Agents.2010Jun;35(6):610–612. https://doi.org/10.1016/j.ijantimicag.2010.01.02410.1016/j.ijantimicag.2010.01.02420206479Search in Google Scholar

Hu L, Liu Y, Deng L, Zhong Q, Hang Y, Wang Z, Zhan L, Wang L, Yu F. Outbreak by ventilator-associated ST11 K. pneumoniae with co-production of CTX-M-24 and KPC-2 in a SICU of a tertiary teaching hospital in central China. Front Microbiol. 2016 Aug 02; 7:1190. https://doi.org/10.3389/fmicb.2016.01190HuLLiuYDengLZhongQHangYWangZZhanLWangLYuF. Outbreak by ventilator-associated ST11 K. pneumoniae with co-production of CTX-M-24 and KPC-2 in a SICU of a tertiary teaching hospital in central China. Front Microbiol.2016Aug02; 7:1190. https://doi.org/10.3389/fmicb.2016.0119010.3389/fmicb.2016.01190497048727531996Search in Google Scholar

Hussein K, Sprecher H, Mashiach T, Oren I, Kassis I, Finkelstein R. Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns. Infect Control Hosp Epidemiol. 2009 Jul;30(7):666–671. https://doi.org/10.1086/598244HusseinKSprecherHMashiachTOrenIKassisIFinkelsteinR. Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns. Infect Control Hosp Epidemiol.2009Jul;30(7):666–671. https://doi.org/10.1086/59824410.1086/59824419496647Search in Google Scholar

Ji S, Lv F, Du X, Wei Z, Fu Y, Mu X, Jiang Y, Yu Y. Cefepime combined with amoxicillin/clavulanic acid: a new choice for the KPC-producing K. pneumoniae infection. Int J Infect Dis. 2015 Sep;38:108–114. https://doi.org/10.1016/j.ijid.2015.07.024JiSLvFDuXWeiZFuYMuXJiangYYuY. Cefepime combined with amoxicillin/clavulanic acid: a new choice for the KPC-producing K. pneumoniae infection. Int J Infect Dis.2015Sep;38:108–114. https://doi.org/10.1016/j.ijid.2015.07.02410.1016/j.ijid.2015.07.02426255892Search in Google Scholar

Kaczmarek FM, Dib-Hajj F, Shang W, Gootz TD. High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla(ACT-1) beta-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoe. Antimicrob Agents Chemother. 2006 Oct;50(10):3396–3406. https://doi.org/10.1128/AAC.00285-06KaczmarekFMDib-HajjFShangWGootzTD. High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla(ACT-1) beta-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoe. Antimicrob Agents Chemother.2006Oct;50(10):3396–3406. https://doi.org/10.1128/AAC.00285-0610.1128/AAC.00285-06161009917005822Search in Google Scholar

Kitchel B, Rasheed JK, Patel JB, Srinivasan A, Navon-Venezia S, Carmeli Y, Brolund A, Giske CG. Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrob Agents Chemother. 2009 Aug;53(8):3365–3370. https://doi.org/10.1128/AAC.00126-09KitchelBRasheedJKPatelJBSrinivasanANavon-VeneziaSCarmeliYBrolundAGiskeCG. Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrob Agents Chemother.2009Aug;53(8):3365–3370. https://doi.org/10.1128/AAC.00126-0910.1128/AAC.00126-09271558019506063Search in Google Scholar

Kofteridis DP, Valachis A, Dimopoulou D, Maraki S, Christidou A, Mantadakis E, Samonis G. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization: A case-case-control study. J Infect Chemother. 2014 May;20(5):293–297. https://doi.org/10.1016/j.jiac.2013.11.007KofteridisDPValachisADimopoulouDMarakiSChristidouAMantadakisESamonisG. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization: A case-case-control study. J Infect Chemother.2014May;20(5):293–297. https://doi.org/10.1016/j.jiac.2013.11.00710.1016/j.jiac.2013.11.00724703709Search in Google Scholar

Kumar M, Shankar C, Baskaran A, Paul M, Ponmudi N, Santhanam S, Michael J, Veeraraghavan B. Molecular characterisation for clonality and transmission dynamics of an outbreak of Klebsiella pneumoniae amongst neonates in a tertiary care centre in South India. Indian J Med Microbiol. 2018;36(1):54–60. https://doi.org/10.4103/ijmm.IJMM_17_426KumarMShankarCBaskaranAPaulMPonmudiNSanthanamSMichaelJVeeraraghavanB. Molecular characterisation for clonality and transmission dynamics of an outbreak of Klebsiella pneumoniae amongst neonates in a tertiary care centre in South India. Indian J Med Microbiol.2018;36(1):54–60. https://doi.org/10.4103/ijmm.IJMM_17_42610.4103/ijmm.IJMM_17_42629735827Search in Google Scholar

Lester CH, Olsen SS, Jakobsen L, Arpi M, Fuursted K, Hansen DS, Heltberg O, Holm A, Højbjerg T, Jensen KT, et al. Emergence of extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae in Danish hospitals; this is in part explained by spread of two CTX-M-15 clones with multilocus sequence types 15 and 16 in Zealand. Int J Antimicrob Agents. 2011 Aug;38(2):180–182. https://doi.org/10.1016/j.ijantimicag.2011.03.018LesterCHOlsenSSJakobsenLArpiMFuurstedKHansenDSHeltbergOHolmAHøjbjergTJensenKT. Emergence of extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae in Danish hospitals; this is in part explained by spread of two CTX-M-15 clones with multilocus sequence types 15 and 16 in Zealand. Int J Antimicrob Agents.2011Aug;38(2):180–182. https://doi.org/10.1016/j.ijantimicag.2011.03.01810.1016/j.ijantimicag.2011.03.01821612893Search in Google Scholar

Logan LK, Weinstein RA. The epidemiology of carbapenem-resistant Enterobacteriaceae: The impact and evolution of a global menace. J Infect Dis. 2017. 215(suppl_1):S28-S36.LoganLKWeinsteinRA. The epidemiology of carbapenem-resistant Enterobacteriaceae: The impact and evolution of a global menace. J Infect Dis.2017. 215(suppl_1):S28-S36.10.1093/infdis/jiw282585334228375512Search in Google Scholar

Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, Lynfield R, Maloney M, McAllister-Hollod L, Nadle J, et al.; Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team. Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014 Mar 27;370(13):1198–1208. https://doi.org/10.1056/NEJMoa1306801MagillSSEdwardsJRBambergWBeldavsZGDumyatiGKainerMALynfieldRMaloneyMMcAllister-HollodLNadleJet al.; Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team. Multistate point-prevalence survey of health care-associated infections. N Engl J Med.2014Mar27;370(13):1198–1208. https://doi.org/10.1056/NEJMoa130680110.1056/NEJMoa1306801464834324670166Search in Google Scholar

Maltezou HC, Giakkoupi P, Maragos A, Bolikas M, Raftopoulos V, Papahatzaki H, Vrouhos G, Liakou V, Vatopoulos AC. Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece). J Infect. 2009 Mar;58(3):213–219. https://doi.org/10.1016/j.jinf.2009.01.010MaltezouHCGiakkoupiPMaragosABolikasMRaftopoulosVPapahatzakiHVrouhosGLiakouVVatopoulosAC. Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece). J Infect.2009Mar;58(3):213–219. https://doi.org/10.1016/j.jinf.2009.01.01010.1016/j.jinf.2009.01.01019246099Search in Google Scholar

Martin RM, Bachman MA. Colonization, infection, and the accessory genome of Klebsiella pneumoniae. Front Cell Infect Microbiol. 2018 Jan 22;8:4. https://doi.org/10.3389/fcimb.2018.00004MartinRMBachmanMA. Colonization, infection, and the accessory genome of Klebsiella pneumoniae. Front Cell Infect Microbiol.2018Jan22;8:4. https://doi.org/10.3389/fcimb.2018.0000410.3389/fcimb.2018.00004578654529404282Search in Google Scholar

Mathers AJ, Peirano G, Pitout JDD. The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae. Clin Microbiol Rev. 2015 Jul;28(3):565–591. https://doi.org/10.1128/CMR.00116-14MathersAJPeiranoGPitoutJDD. The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae. Clin Microbiol Rev.2015Jul;28(3):565–591. https://doi.org/10.1128/CMR.00116-1410.1128/CMR.00116-14440562525926236Search in Google Scholar

Nordmann P, Poirel L, Carrër A, Toleman MA, Walsh TR. How to detect NDM-1 producers. J Clin Microbiol. 2011 Feb 01;49(2): 718–721. https://doi.org/10.1128/JCM.01773-10NordmannPPoirelLCarrërATolemanMAWalshTR. How to detect NDM-1 producers. J Clin Microbiol.2011Feb01;49(2): 718–721. https://doi.org/10.1128/JCM.01773-1010.1128/JCM.01773-10304350721123531Search in Google Scholar

Papadimitriou-Olivgeris M, Marangos M, Fligou F, Christofidou M, Sklavou C, Vamvakopoulou S, Anastassiou ED, Filos KS. KPC-producing Klebsiella pneumoniae enteric colonization acquired during intensive care unit stay: the significance of risk factors for its development and its impact on mortality. Diagn Microbiol Infect Dis. 2013 Oct;77(2):169–173. https://doi.org/10.1016/j.diagmicrobio.2013.06.007Papadimitriou-OlivgerisMMarangosMFligouFChristofidouMSklavouCVamvakopoulouSAnastassiouEDFilosKS. KPC-producing Klebsiella pneumoniae enteric colonization acquired during intensive care unit stay: the significance of risk factors for its development and its impact on mortality. Diagn Microbiol Infect Dis.2013Oct;77(2):169–173. https://doi.org/10.1016/j.diagmicrobio.2013.06.00710.1016/j.diagmicrobio.2013.06.00723886789Search in Google Scholar

Qi Y, Wei Z, Ji S, Du X, Shen P, Yu Y. ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China. J Antimicrob Chemother. 2011 Feb;66(2):307–312. https://doi.org/10.1093/jac/dkq431QiYWeiZJiSDuXShenPYuY. ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China. J Antimicrob Chemother.2011Feb;66(2):307–312. https://doi.org/10.1093/jac/dkq43110.1093/jac/dkq43121131324Search in Google Scholar

Queenan AM, Bush K. Carbapenemases: the versatile β-Lactamases. Clin Microbiol Rev. 2007 Jul;20(3):440–458. https://doi.org/10.1128/CMR.00001-07QueenanAMBushK. Carbapenemases: the versatile β-Lactamases. Clin Microbiol Rev.2007Jul;20(3):440–458. https://doi.org/10.1128/CMR.00001-0710.1128/CMR.00001-07193275017630334Search in Google Scholar

Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother. 2008 Mar;52(3):1028–1033. https://doi.org/10.1128/AAC.01020-07SchwaberMJKlarfeld-LidjiSNavon-VeneziaSSchwartzDLeavittACarmeliY. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother.2008Mar;52(3):1028–1033. https://doi.org/10.1128/AAC.01020-0710.1128/AAC.01020-07225852718086836Search in Google Scholar

Snitkin ES, Zelazny AM, Thomas PJ, Stock F, Henderson DK, Palmore TN, Segre JA; NISC Comparative Sequencing Program Group. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med. 2012 Aug 22;4(148):148ra116. https://doi.org/10.1126/scitranslmed.3004129SnitkinESZelaznyAMThomasPJStockFHendersonDKPalmoreTNSegreJA; NISC Comparative Sequencing Program Group. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med.2012Aug22;4(148):148ra116. https://doi.org/10.1126/scitranslmed.300412910.1126/scitranslmed.3004129352160422914622Search in Google Scholar

Tian L, Zhang Z, Sun Z. Antimicrobial resistance trends in bloodstream infections at a large teaching hospital in China: a 20-year surveillance study (1998–2017). Antimicrob Resist Infect Control. 2019 Dec;8(1):86. https://doi.org/10.1186/s13756-019-0545-zTianLZhangZSunZ. Antimicrobial resistance trends in bloodstream infections at a large teaching hospital in China: a 20-year surveillance study (1998–2017). Antimicrob Resist Infect Control.2019Dec;8(1):86. https://doi.org/10.1186/s13756-019-0545-z10.1186/s13756-019-0545-z654053631161033Search in Google Scholar

uz Zaman T, Aldrees M, Al Johani SM, Alrodayyan M, Aldughashem FA, Balkhy HH. Multi-drug carbapenem-resistant Klebsiella pneumoniae infection carrying the OXA-48 gene and showing variations in outer membrane protein 36 causing an outbreak in a tertiary care hospital in Riyadh, Saudi Arabia. Int J Infect Dis. 2014 Nov;28:186–192. https://doi.org/10.1016/j.ijid.2014.05.021uz ZamanTAldreesMAl JohaniSMAlrodayyanMAldughashemFABalkhyHH. Multi-drug carbapenem-resistant Klebsiella pneumoniae infection carrying the OXA-48 gene and showing variations in outer membrane protein 36 causing an outbreak in a tertiary care hospital in Riyadh, Saudi Arabia. Int J Infect Dis.2014Nov;28:186–192. https://doi.org/10.1016/j.ijid.2014.05.02110.1016/j.ijid.2014.05.02125245001Search in Google Scholar

Vardakas KZ, Matthaiou DK, Falagas ME, Antypa E, Koteli A, Antoniadou E. Characteristics, risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in the intensive care unit. J Infect. 2015 Jun;70(6):592–599. https://doi.org/10.1016/j.jinf.2014.11.003VardakasKZMatthaiouDKFalagasMEAntypaEKoteliAAntoniadouE. Characteristics, risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in the intensive care unit. J Infect.2015Jun;70(6):592–599. https://doi.org/10.1016/j.jinf.2014.11.00310.1016/j.jinf.2014.11.00325447713Search in Google Scholar

Wang Z, Li M, Shen X, Wang L, Liu L, Hao Z, Duan J, Yu F. Outbreak of blaNDM-5 -Harboring Klebsiella pneumoniae ST290 in a Tertiary Hospital in China. Microb Drug Resist. 2019 Dec 01;25(10):1443–1448. https://doi.org/10.1089/mdr.2019.0046WangZLiMShenXWangLLiuLHaoZDuanJYuF. Outbreak of bla_NDM-5 -Harboring Klebsiella pneumoniae ST290 in a Tertiary Hospital in China. Microb Drug Resist.2019Dec01;25(10):1443–1448. https://doi.org/10.1089/mdr.2019.004610.1089/mdr.2019.004631334685Search in Google Scholar

WHO. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics [Internet]. Geneva (Switzerland): World Health Organization; 2017 [cited 2017 February 27]. Available from https://www.who.int/medicines/publications/global-priority-list-antibiotic-resistant-bacteria/en/WHO. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics [Internet]. Geneva (Switzerland): World Health Organization; 2017[cited 2017 February 27]. Available fromhttps://www.who.int/medicines/publications/global-priority-list-antibiotic-resistant-bacteria/en/Search in Google Scholar

Wu W, Feng Y, Tang G, Qiao F, McNally A, Zong Z. NDM metallo-β-Lactamases and their bacterial producers in health care settings. Clin Microbiol Rev. 2019 Jan 30;32(2):e00115-18. https://doi.org/10.1128/CMR.00115-18WuWFengYTangGQiaoFMcNallyAZongZ. NDM metallo-β-Lactamases and their bacterial producers in health care settings. Clin Microbiol Rev.2019Jan30;32(2):e00115-18. https://doi.org/10.1128/CMR.00115-1810.1128/CMR.00115-18643112430700432Search in Google Scholar

Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, Walsh TR. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 2009 Dec;53(12): 5046–5054. https://doi.org/10.1128/AAC.00774-09YongDTolemanMAGiskeCGChoHSSundmanKLeeKWalshTR. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother.2009Dec;53(12): 5046–5054. https://doi.org/10.1128/AAC.00774-0910.1128/AAC.00774-09278635619770275Search in Google Scholar

Yu F, Hu L, Zhong Q, Hang Y, Liu Y, Hu X, Ding H, Chen Y, Xu X, Fang X, et al. Dissemination of Klebsiella pneumoniae ST11 isolates with carbapenem resistance in integrated and emergency intensive care units in a Chinese tertiary hospital. J Med Microbiol. 2019 Jun 01;68(6):882–889. https://doi.org/10.1099/jmm.0.000981YuFHuLZhongQHangYLiuYHuXDingHChenYXuXFangX. Dissemination of Klebsiella pneumoniae ST11 isolates with carbapenem resistance in integrated and emergency intensive care units in a Chinese tertiary hospital. J Med Microbiol.2019Jun01;68(6):882–889. https://doi.org/10.1099/jmm.0.00098110.1099/jmm.0.00098131050634Search in Google Scholar

Yu F, Ying Q, Chen C, Li T, Ding B, Liu Y, Lu Y, Qin Z, Parsons C, Salgado C, et al. Outbreak of pulmonary infection caused by Klebsiella pneumoniae isolates harbouring blaIMP-4 and blaDHA-1 in a neonatal intensive care unit in China. J Med Microbiol. 2012 Jul 01;61(7):984–989. https:0/doi.org/10.1099/jmm.0.043000-0YuFYingQChenCLiTDingBLiuYLuYQinZParsonsCSalgadoC. Outbreak of pulmonary infection caused by Klebsiella pneumoniae isolates harbouring bla_IMP-4 and bla_DHA-1 in a neonatal intensive care unit in China. J Med Microbiol.2012Jul01;61(7):984–989. https:0/doi.org/10.1099/jmm.0.043000-010.1099/jmm.0.043000-022466031Search in Google Scholar

Zhang P, Shi Q, Hu H, Hong B, Wu X, Du X, Akova M, Yu Y. Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China. Clin Microbiol Infect. 2020 Jan;26(1):124.e1-124.e4. https://doi.org/10.1016/j.cmi.2019.08.020ZhangPShiQHuHHongBWuXDuXAkovaMYuY. Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China. Clin Microbiol Infect.2020Jan;26(1):124.e1-124.e4. https://doi.org/10.1016/j.cmi.2019.08.02010.1016/j.cmi.2019.08.02031494252Search in Google Scholar

Zhang R, Wang XD, Cai JC, Zhou HW, Lv HX, Hu QF, Chen GX. Outbreak of Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae with high qnr prevalence in a Chinese hospital. J Med Microbiol. 2011 Jul 01;60(7):977–982. https://doi.org/10.1099/jmm.0.015826-0ZhangRWangXDCaiJCZhouHWLvHXHuQFChenGX. Outbreak of Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae with high qnr prevalence in a Chinese hospital. J Med Microbiol.2011Jul01;60(7):977–982. https://doi.org/10.1099/jmm.0.015826-010.1099/jmm.0.015826-021393450Search in Google Scholar

Polish Journal of Microbiology

A Polyclonal Spread Emerged: Characteristics of Carbapenem-Resistant Klebsiella pneumoniae Isolates from the Intensive Care Unit in a Chinese Tertiary Hospital

ZHENGZHENG WANG,
ZHENGZHENG WANG,
FANGYOU YU,
FANGYOU YU,
XIAOFEI SHEN and
XIAOFEI SHEN and
MEILAN LI
MEILAN LI

Published Online: 08 Sep 2020

Volume & Issue: Volume 69 (2020) - Issue 3 (September 2020)

Page range: 311 - 319

Received: 31 Mar 2020

Accepted: 22 Jul 2020

Journal & Issue Details

Polish Journal of Microbiology

PDF Preview

Article

Fig. 1.

Fig. 2.

Figures & Tables

Fig. 1.

Fig. 2.

The corresponding bacterial characteristics and medical records of patients with CRKP acquisition.

References

Recent Articles

Polish Journal of Microbiology

A Polyclonal Spread Emerged: Characteristics of Carbapenem-Resistant Klebsiella pneumoniae Isolates from the Intensive Care Unit in a Chinese Tertiary Hospital

ZHENGZHENG WANG,ZHENGZHENG WANG,FANGYOU YU,FANGYOU YU,XIAOFEI SHEN andXIAOFEI SHEN andMEILAN LIMEILAN LI

Published Online: 08 Sep 2020

Volume & Issue: Volume 69 (2020) - Issue 3 (September 2020)

Page range: 311 - 319

Received: 31 Mar 2020

Accepted: 22 Jul 2020

Journal & Issue Details

Polish Journal of Microbiology

PDF Preview

Article

Fig. 1.

Fig. 2.

Figures & Tables

Fig. 1.

Fig. 2.

The corresponding bacterial characteristics and medical records of patients with CRKP acquisition.

References

Recent Articles

ZHENGZHENG WANG,
ZHENGZHENG WANG,
FANGYOU YU,
FANGYOU YU,
XIAOFEI SHEN and
XIAOFEI SHEN and
MEILAN LI
MEILAN LI